|
VPS26B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.848300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.693800E-02 |
| Normal-vs-Stage2 |
5.252800E-01 |
| Normal-vs-Stage3 |
1.821610E-02 |
| Normal-vs-Stage4 |
8.783500E-03 |
| Stage1-vs-Stage2 |
1.253530E-02 |
| Stage1-vs-Stage3 |
2.217600E-01 |
| Stage1-vs-Stage4 |
1.879620E-01 |
| Stage2-vs-Stage3 |
4.500000E-03 |
| Stage2-vs-Stage4 |
2.540800E-03 |
| Stage3-vs-Stage4 |
7.674200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.399740E-02 |
| Normal-vs-AfricanAmerican |
6.165600E-01 |
| Normal-vs-Asian |
5.237800E-02 |
| Caucasian-vs-AfricanAmerican |
2.515000E-01 |
| Caucasian-vs-Asian |
8.959800E-01 |
| AfricanAmerican-vs-Asian |
3.716000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.901780E-02 |
| Normal-vs-Female |
1.085030E-01 |
| Male-vs-Female |
2.018200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.171600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.464100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.342600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.659900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.757600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.682200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.673760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.655000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.928560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.920230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.175030E-01 |
| Classical-VS-Follicular |
1.028420E-02 |
| Classical-VS-Other |
2.754400E-01 |
| Classical-VS-Normal |
1.586000E-02 |
| Tall-VS-Follicular |
1.559490E-03 |
| Tall-VS-Other |
5.867200E-01 |
| Tall-VS-Normal |
5.039800E-03 |
| Follicular-VS-Other |
1.298780E-01 |
| Follicular-VS-Normal |
7.154200E-01 |
| Other-VS-Normal |
4.839800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.546400E-01 |
| Normal-vs-N1 |
1.76401999999465E-05 |
| N0-vs-N1 |
2.33609999999995E-05 |
|
|
